Sofiya Micheva-Viteva

Title: Sofiya Micheva-Viteva: Innovator in HIV Research

Introduction

Sofiya Micheva-Viteva is a prominent inventor based in Los Alamos, NM (US). She has made significant contributions to the field of HIV research, particularly in developing models for high throughput screening. With a total of 2 patents, her work is paving the way for advancements in HIV treatment and understanding.

Latest Patents

Micheva-Viteva's latest patents include an innovative HIV-1 latency model for high throughput screening. This model provides isolated, latently infected T cell lines that can be utilized to discover compounds capable of activating HIV-1. The T cell lines harbor a latent HIV-1 derived vector provirus, which, upon activation, expresses a marker for late viral gene expression due to the insertion of the marker gene in the position of the HIV-1 envelope. This groundbreaking work is crucial for identifying potential therapeutic compounds.

Career Highlights

Sofiya Micheva-Viteva is affiliated with the University of Medicine and Dentistry of New Jersey, where she continues her research and development efforts. Her academic background and dedication to her field have established her as a key figure in HIV research.

Collaborations

Micheva-Viteva has collaborated with notable colleagues, including Joseph P Dougherty and Stuart W Peltz. These partnerships enhance her research capabilities and contribute to the advancement of innovative solutions in the fight against HIV.

Conclusion

Sofiya Micheva-Viteva's contributions to HIV research through her patents and collaborations highlight her role as an influential inventor. Her work is essential for the ongoing battle against HIV, and her innovative approaches are likely to lead to significant breakthroughs in treatment.